Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
about
Vitamin K supplementation during pregnancy for improving outcomesManagement of epilepsy in womenManagement of epilepsy during pregnancy: an updateAntiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: an update.Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and TechnologyManagement issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment SubcommitThe International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.Vitamin K--what, why, and when.Anti-epileptic drugs in pregnancy: current safety and other issues.Pregnancy, epilepsy, and anticonvulsants.Does vitamin K prophylaxis prevent bleeding in neonates exposed to enzyme-inducing antiepileptic drugs in utero?The pharmacology of bipolar disorder during pregnancy and breastfeeding.Induction of endogenous pathways by antiepileptics and clinical implications.Management of epilepsy in women of childbearing age: practical recommendations.Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers.Therapy insight: clinical management of pregnant women with epilepsy.In utero exposure to antiepileptic drugs: teratogenicity and neonatal morbidity.Women and epilepsy: review and practical recommendations.Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohortsItalian consensus conference on epilepsy and pregnancy, labor and puerperium.The management of epilepsy in pregnancy.Epilepsy, sex hormones and antiepileptic drugs in female patients.Management of women with epilepsy: from preconception to post-partum.Update on management of epilepsy in women for the non-neurologist.Treatment considerations during pregnancy for women with epilepsy.Pregnancy, delivery, and outcome for the child in maternal epilepsy.Vitamin K deficiency in severely disabled children.Managing epilepsy during pregnancy: assessing risk and optimizing care.Vitamin K supplementation during pregnancy for improving outcomes: a systematic review and meta-analysisNew-Onset Seizures in PregnancyAnticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study
P2860
Q24201482-A2B10046-7466-4846-BF36-7A6E5B22A64AQ24680158-10C629CC-CD4E-4EC3-B800-D75DF90D211BQ26752470-238D84B5-D077-4D0C-92D7-5A25CB5754A3Q34406217-56F644B6-0881-4D66-BE6E-C150D093D58DQ34606995-76AC4F83-1CD7-4BD5-8F30-DBA1431DBBC7Q34985706-84C28B39-B5B0-4629-BA70-F6E9F527B16AQ34998063-5A52D820-9B4B-4695-BF18-74287DBE9DDAQ35070982-A7455172-51CC-4672-B537-C420C24D44FFQ35095179-C90B0C1B-6C40-44B0-97C8-197344F361E9Q35236942-D0FD1CC2-296B-4440-8C32-F3237192F030Q35607163-FF0A9855-18A4-47FC-B79E-89F8ACFF0369Q35779335-6AF5AE2E-DF46-4662-9D98-7D6C42A845C8Q36263605-05B994A5-528D-4009-B6B8-B0194853A3A5Q36476623-12083CE8-13C9-48B6-B28C-A2E986E8BCF6Q36476778-2D346B01-9A85-44D7-9715-AF2AD79AAD1AQ36577270-77563EE4-A643-4F3A-805A-F6A5CADE5FCBQ36745801-626E9B5B-EF01-470B-8182-8CB2DE286B31Q36752925-30E19C5F-3C09-4EF3-8064-0B97E353B61AQ37138858-FBACF65A-B282-484C-9AA9-42C433F6F440Q37363241-7F570E20-BBC8-4475-B7FF-BC71AF9A0699Q37477199-52A05BE2-623D-4753-B447-BB549C1BEE8EQ37642006-BB3F7C65-95B2-4F26-A6DC-15781B918F84Q38655275-0520027E-F368-45DB-B4B4-186B551E6247Q38895955-1B785941-1798-4133-BD73-C43C5CF176ACQ43267058-747E9664-BB06-415D-A33C-B86B6D9D6455Q45986025-E5276183-461A-4231-9467-458AC021F936Q47976156-31E4820D-9E27-44BF-BD11-471D2A99CE59Q48237709-76EE7FCF-C7B5-4536-BDA8-99FB3E8DE3F5Q57174221-C36A3447-9B24-4CB1-B077-31C8C8B56130Q58623892-223CF4C0-EA6C-4AC5-9298-941F78C66ECFQ58859779-1885A712-2084-4B49-88FF-E510F055827F
P2860
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@en
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@nl
type
label
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@en
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@nl
prefLabel
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@en
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@nl
P2093
P356
P1433
P1476
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.
@en
P2093
Erja Kaaja
Riitta Matila
Risto Kaaja
Vilho Hiilesmaa
P304
P356
10.1212/WNL.58.4.549
P407
P577
2002-02-01T00:00:00Z